CardiologyOnline.net

Cardiology Xagena

XagenaNewsletter
Xagena Mappa
Medical Meeting
Dermabase.it

Search results for "Resistant hypertension"

Darusentan, an endothelin receptor antagonist ( ERA ) for the treatment of resistant hypertension, met its co-primary efficacy endpoints of change from baseline to week 14 in trough sitting systolic b ...


Up to 10% of patients with high blood pressure are resistant to treatment, which puts them at increased risk of cardiovascular events, including myocardial infarction. Clinical trials have shown that ...


Renal denervation ( RDN ) with radiofrequency ablation substantially reduces blood pressure in patients with treatment-resistant hypertension. Researchers have assessed the long-term antihypertensive ...


Resistant hypertension increases the risk of stroke by 35% in women and 20% in elderly Taiwanese patients, according to research presented at ESC Congress by Dr Kuo-Yang Wang from Taiwan. The findin ...


Renal denervation ( RDN ) is a therapy that targets treatment-resistant hypertension ( TRH ). The Symplicity HTN-1 and Symplicity HTN-2 trials reported response rates of more than 80%; however, sh ...